HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serology of Chlamydia trachomatis in infants.

Abstract
Sera from 502 infants with pneumonia were tested for antibodies to Chlamydia trachomatis by the microimmunofluorescence test; 175 (34.9%) were positive for IgM antibodies (titer, greater than or equal to 1:32). Chlamydiae were recovered from 42 (46.2%) of 91 IgM antibody-positive infants as compared with six (3.3%) of 181 IgM antibody-negative infants (P less than 0.0001). Two (4%) of 46 of the infants with inclusion conjunctivitis, but not pneumonia, had titers of IgM antibody of greater than or equal to 1:32; both shed the organism from the rectum. IgM antibody to C. trachomatis is not maternally transmitted to infants and was detected at a low rate (1.1%) in infants with nonpneumonic conditions. Diagnosis of pneumonia due to Chlamydia in infants by isolation of the agent is slow and unreliable. High levels of IgM antibody (greater than 1:32) appear to reflect a systemic chlamydial infection and offer the possibility of a same-day diagnosis. Thus, the detection of specific IgM antibodies to C. trachomatis may be the method of choice in diagnosing chlamydial pneumonia in infants.
AuthorsJ Schachter, M Grossman, P H Azimi
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 146 Issue 4 Pg. 530-5 (Oct 1982) ISSN: 0022-1899 [Print] United States
PMID6750008 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin M
Topics
  • Antibodies, Viral (analysis)
  • Chlamydia Infections (diagnosis, immunology)
  • Chlamydia trachomatis (immunology, isolation & purification)
  • Conjunctivitis, Inclusion (immunology)
  • Fluorescent Antibody Technique
  • Humans
  • Immunity, Maternally-Acquired
  • Immunoglobulin G (analysis)
  • Immunoglobulin M (analysis)
  • Infant
  • Infant, Newborn
  • Pneumonia (etiology, immunology)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: